- Cancer, immune drugmakers dominate VC funding so far in 2026<figure><div><img src="https://imgproxy.divecdn.com/nnTWCzHBd9_O2uNBVPF6xmxcO0M-nRFDpca5z-2Xchs/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDMwNzQzODA0LmpwZ…BioPharma Dive · 20d ago↗ source
- Salk Institute’s president on NIH cuts, ‘all in’ on AI, and the Year of the BrainSAN DIEGO — From the president’s office at the Salk Institute, Gerald Joyce has a quintessential California view of hang gliders soaring over the Pacific Ocean. It’s been a little more turbulent…Endpoints · 20d ago↗ source
- Beyond Boston: Unlikely cities stake biotech claims<figure><div><img src="https://imgproxy.divecdn.com/lHTPvWvEMjW-n2hvHXgcGrQIAti_O2dHFFQGdwbcrzk/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMjI2NDY4ODE4LmpwZ…